HCM
WST icon

Highbridge Capital Management’s West Pharmaceutical WST Stock Holding History

Highbridge Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-3,120
Closed -$232K – 1630
2016
Q3 		$232K Sell
3,120
-717
-19% -$56.9K ﹤0.01% 1125
2016
Q2 		$291K Buy
+3,837
New +$279K ﹤0.01% 1078
2015
Q4 		– Sell
-61,425
Closed -$3.32M – 1846
2015
Q3 		$3.32M Buy
+61,425
New +$3.58M 0.05% 399

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Highbridge Capital Management's WST Position: Q4 2016 in Review

Highbridge Capital Management sold out of West Pharmaceutical (WST) in Q4 2016, closing a stake of 3,120 shares — an estimated $232K sold.

Highbridge Capital Management first reported a position in WST in Q3 2015 and held it in 3 quarters. The position peaked at $3.32M in Q3 2015. 288 funds tracked by Wall St. Rank hold WST as of Q4 2016.

  • Highbridge Capital Management reported no remaining West Pharmaceutical position as of Q4 2016 after selling out during the quarter.
  • Highbridge Capital Management sold 3,120 West Pharmaceutical shares in Q4 2016, an estimated $232K.
  • Highbridge Capital Management first reported a position in West Pharmaceutical in Q3 2015 and held it in 3 quarters.
  • Highbridge Capital Management's West Pharmaceutical position peaked at $3.32M in Q3 2015.
  • 288 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2016.

Based on Highbridge Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.